Major shareholder announcement – BlackRock, Inc.
11 April 2024 - 12:50AM
Major shareholder announcement – BlackRock, Inc.
ANNOUNCEMENT NO. 260
Major shareholder announcement
Major shareholder announcement – BlackRock,
Inc.
Pursuant to Section 30 of the Capital Markets Act,
it is hereby announced that BlackRock, Inc. has informed ChemoMetec
A/S that BlackRock Investment Management (UK) Limited on 9 April
2024, increased its holding of voting rights attached to shares and
voting rights in ChemoMetec A/S to above 10%, and that the holding
thus exceeds the 10 per cent limit in section 38 of the Capital
Markets Act.
The aggregate holding of shares and voting rights
of BlackRock, Inc. in ChemoMetec A/S amounts to 13,48% of the total
share capital and voting rights in ChemoMetec A/S.
Additional information
Niels Høy Nielsen, CFOTelephone (+45) 2551 8724
About ChemoMetec A/S
ChemoMetec develops, manufactures and markets
instruments for cell counting and a wide range of other
measurements. ChemoMetec’s instruments are marketed to the
pharmaceutical, biotech and agricultural industries worldwide.
ChemoMetec’s customers include some of the world’s leading
pharmaceutical companies, such as Novartis, Novo Nordisk, H.
Lundbeck, Merck, AstraZeneca and Johnson & Johnson.
ChemoMetec was founded in 1997 and is listed on
Nasdaq OMX Copenhagen. For more information, go to
www.chemometec.com
Chemometec AS (TG:CHY)
Historical Stock Chart
From May 2024 to Jun 2024
Chemometec AS (TG:CHY)
Historical Stock Chart
From Jun 2023 to Jun 2024